MarketInOut Stock Screener Log In | Sign Up
 

Faeth Therapeutics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Faeth Therapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization471.59 mln
Float18.39 mln
Earnings Date11/10/2026

Piotroski F-Score

3 / 9
Below average

1-Year Forecast

55.38
Transformational upside

Relative Strength

5 / 100
Severely lagging

Debt / Equity

0.00
Debt-free

Pre-Tax Margin

4,031%
Exceptional margin

ROE

-222
Deeply negative

Business Description

Faeth Therapeutics, formerly Sensei Biotherapeutics, is a clinical-stage biotech company based in Rockville, Maryland, focused on developing new treatments for cancer. Its lead programs include PIKTOR, which targets a key cell growth pathway in endometrial and breast cancer, and Solnerstotug, an antibody designed to help the immune system fight solid tumors. The company also has several earlier-stage drugs in development aimed at treating various solid tumor types.

Key Fundamentals

EPS-60.86
ROE-222
ROIC-1,199
ROA-205
Interest Cover-22,091
EBITDA, mln-195
EV / EBITDA-0.41
EV / EBIT-0.41

Quote Details

Last 17.08
Change -3.02 (-15.02%)
Open 20.00
Volume 353,705
Turnover 6,041,282
Average Volume 336,769

Financial Ratios

Pre-Tax Profit Margin4,031
Leverage Ratio1.09
Current Ratio19.69
Price / Book4.41
Price / Tangible Book4.41
Debt / Equity0.00

Financial Strength

Piotroski F-Score 3 / 9
1-Year Target Price55.38
Short Ratio4.76
Short % of Float8.13

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -9.15% 10 / 100   
1 Month -41.2% 7 / 100   
2 Months -39.41% 12 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog